2C53.Y

ICD-11 MMS 2026-01

Other specified malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Exclusions from above levels

http://id.who.int/icd/entity/1965082709 – Malignant mesenchymal neoplasms
http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Sibling codes

2C53.0 – Adenocarcinoma involving overlapping sites of retroperitoneum, peritoneum or omentum
2C53.1 – Mesothelioma involving overlapping sites of retroperitoneum, peritoneum or omentum
2C53.Z – Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum, unspecified

Foundation entity

Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum – http://id.who.int/icd/entity/131965197

Allowed postcoordination axes

Part of: 2C53: Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum › 02: Neoplasms